β amyloïde (1-42) (vervormd) (TFA)

β Amyloid (1-42) (scrambled) TFA is a negative control of β-Amyloid (1-42), human TFA.

12352209

Amyloid-β

Neuronal Signaling

Neurological Disease

99.79

DMSO : 25 mg/mL (ultrasonic)

O=C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H](CC(O)=O)C(N[C@@H](CO)C(N[C@@H](CC1=CNC=N1)C(N[C@@H](C(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H](C)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CCSC)C(N[C@@H](CCC(O)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(NCC(N[C@@H](CC4=CNC=N4)C(N[C@@H](C(C)C)C(N[C@@H](CC5=CC=CC=C5)C(NCC(NCC(N[C@@H](CCCCN)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC6=CC=CC=C6)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(C)C)C(NCC(N[C@@H](CO)C(N[C@@H](CC7=CNC=N7)C(N[C@@H](CC(N)=O)C(N[C@@H](C(C)C)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C)N.O=C(O)C(F)(F)F.[x]

C203H311N55O60S.xC2HF3O2

4514.04 (free base)

[1]Vadukul DM, et al. Amyloidogenicity and toxicity of the reverse and scrambled variants of amyloid-β 1-42. FEBS Lett. 2017 Mar;591 (5) :822-830.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P4867A/β-Amyloid-1-42-scrambled-TFA-SDS-MedChemExpress.pdf

Peptides

No Development Reported